HomeCompaniesProfile

Macromoltek

Computational antibody design 


Company Size

11 - 50 employees

Year Founded

2010


About Macromoltek

Macromoltek: Revolutionizing antibody design.

Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

Founders & Key People

Susana Kaufmann

Susana Kaufmann

Co-founder of Macromoltek

Monica Berrondo

Monica Berrondo

Founder/CEO, Macromoltek

Share This Profile

More Companies

Mason

Mason is the fastest way to take smart devices from idea to end user

Rev Genomics

Rev is a biotechnology company creating better plants.

Siglo

Home Internet for urban Latin America

SiPhox

Wearable and At-Home protein monitoring with silicon photonic chips

Quilt Data

Quilt manages data like code so that companies can experiment faster

LotusPay

Recurring payments solution for businesses in India.

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.